THNR is Amplify ETFs's Amplify Weight Loss Drug & Treatment ETF (Health). Trading at $24.77. Current dividend yield: 1.69%.
Dividend snapshot
| Annual dividend rate | $0.42 |
| Current yield | 1.69% |
| Payment frequency | Annually |
| Next ex-dividend date | Dec 30, 2026 |
| Most recent payment date | Dec 31, 2025 |
| Last payment amount | $0.4132 |
| 5-year dividend CAGR | — |
| 3-year dividend CAGR | — |
| Expense ratio | 0.59% |
| Payout ratio | 0% |
| Market cap | $4M |
| Exchange | PCX |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2025-12-30 | $0.4130 |
| 2024-12-30 | $0.2200 |
About THNR
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Track THNR in DiviDrip
Add THNR to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search THNR and add your shares.
- View the THNR Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like THNR.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-25. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.